29th Oct 2007 15:39
Allergy Therapeutics PLC29 October 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing Allergy Therapeutics plcshares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments which may result in the acquisition ofshares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the notification INVESCO plcobligation: 4. Full name of shareholder(s) (if different from 3.): N/A 5. Date of the transaction (and date on which the threshold is 25 October 2007crossed or reached if different): 6. Date on which issuer notified: 26 October 2007 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: A: Voting rights attached to sharesClass/type of Situation previous to Resulting situation after the triggering transactionshares the Triggering transaction if possible Number of Number of Number of Number of voting rights % of voting rightsusing the ISIN Shares Voting sharesCODE Rights Direct Direct Indirect Direct IndirectGB00B02LCQ05 2,762,645 2,762,645 4,162,645 0 4,162,645 0.00% 5.08% ORD £0.001 B: Financial InstrumentsResulting situation after the triggering transactionType of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument Period/ Date that may be acquired if rights the instrument is exercised/ convertedN/A N/A N/A N/A N/A Total (A+B)Number of voting rights % of voting rights4,162,645 5.08% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectivelyheld, if applicable:JP Morgan Chase 2,013,466 Vidacos Nominees 2,149,179 Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.